Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01112514 · ClinicalTrials.gov registry record · NA
Indocyanine Green Fluorescent Molecular Imaging of the Gastrointestinal Tract
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT01112514: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01112514 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01112514, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Standard white light endoscopy involves the passage of a thin, flexible camera into the colon from the anus. Although standard white light endoscopy can detect most polyps and precancerous areas in the gastrointestinal tract and colon, many studies have shown that even the most experienced doctors, under optimal conditions, can miss up to 15-25% of precancerous areas. Thus, there remains a clear need to develop new methods of improving standard white light endoscopy. We are investigating whether indocyanine green (ICG) can serve to highlight areas which are precancerous when the colon is visualized with a special cameral which shines fluorescent light. Information from other studies suggests that this ICG agent may help to visualize blood vessels flowing to precancerous areas in the colon. We are looking at the ability of ICG, in combination with an endoscope which shines fluorescent light, to visualize precancerous areas in the colon.
Interventions
- DRUG indocyanine green
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2010-02 |
| Est. Completion | 2013-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01112514
The ClinicalTrials.gov registry entry for NCT01112514 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which indocyanine green is the first listed.
NCT01112514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01112514 about?
NCT01112514 is a clinical study titled "Indocyanine Green Fluorescent Molecular Imaging of the Gastrointestinal Tract". Standard white light endoscopy involves the passage of a thin, flexible camera into the colon from the anus. Although standard white light endoscopy can detect most polyps and precancerous areas in the gastrointestinal tract and colon, many studies have shown that even the most experienced doctors, ...
What is the current status of trial NCT01112514?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2010-02. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01112514?
The interventions under investigation include: indocyanine green (DRUG).
Who is sponsoring clinical trial NCT01112514?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.